Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Gen Physiol ; 116(5): 599-608, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11055989

RESUMO

Phosphatidylinositol 4,5-bisphosphate (PIP(2)) activates K(ATP) and other inward rectifier (Kir) channels. To determine residues important for PIP(2) regulation, we have systematically mutated each positive charge in the COOH terminus of Kir6.2 to alanine. The effects of these mutations on channel function were examined using (86)Rb efflux assays on intact cells and inside-out patch-clamp methods. Both methods identify essentially the same basic residues in two narrow regions (176-222 and 301-314) in the COOH terminus that are important for the maintenance of channel function and interaction with PIP(2). Only one residue (R201A) simultaneously affected ATP and PIP(2) sensitivity, which is consistent with the notion that these ligands, while functionally competitive, are unlikely to bind to identical sites. Strikingly, none of 13 basic residues in the terminal portion (residues 315-390) of the COOH terminus affected channel function when neutralized. The data help to define the structural requirements for PIP(2) sensitivity of K(ATP) channels. Moreover, the regions and residues defined in this study parallel those uncovered in recent studies of PIP(2) sensitivity in other inward rectifier channels, indicating a common structural basis for PIP(2) regulation.


Assuntos
Trifosfato de Adenosina/metabolismo , Fosfatidilinositol 4,5-Difosfato/farmacologia , Canais de Potássio Corretores do Fluxo de Internalização , Canais de Potássio/fisiologia , Técnicas de Cultura de Células , Humanos , Ligantes , Fosfatidilinositol 4,5-Difosfato/farmacocinética , Mutação Puntual , Canais de Potássio/efeitos dos fármacos , Canais de Potássio/genética , Relação Estrutura-Atividade
2.
ACS Chem Neurosci ; 6(3): 386-92, 2015 Mar 18.
Artigo em Inglês | MEDLINE | ID: mdl-25543978

RESUMO

Transient receptor potential vanilloid 1 ion channel (TRPV1) belongs to the TRP family of ion channels. These channels play a role in many important biological processes such as thermosensation and pain transduction. The TRPV1 channel was reported to be also involved in nociception. Ca(2+) ions are described to participate in the regulation of TRP channels through the interaction with Ca(2+)-binding proteins, such as calmodulin or S100A1. Calmodulin is involved in the Ca(2+)-dependent regulation of TRPV1 via its binding to the TRPV1 C-terminal region. However, the role of the Ca(2+)-binding protein S100A1 in the process of TRP channel regulation remains elusive. Here we characterized a region on the TRPV1 C-terminus responsible for the interaction with S100A1 using biochemical and biophysical tools. We found that this region overlaps with previously identified calmodulin and PIP2 binding sites and that S100A1 competes with calmodulin and PIP2 for this binding site. We identified several positively charged residues within this region, which have crucial impact on S100A1 binding, and we show that the reported S100A1-TRPV1 interaction is calcium-dependent. Taken together, our data suggest a mechanism for the mutual regulation of PIP2 and the Ca(2+)-binding proteins S100A1 and calmodulin to TRPV1.


Assuntos
Fenômenos Biofísicos , Calmodulina/metabolismo , Fosfatidilinositol 4,5-Difosfato/metabolismo , Proteínas S100/metabolismo , Canais de Cátion TRPV/metabolismo , Animais , Sítios de Ligação , Fenômenos Biofísicos/genética , Cálcio/metabolismo , Cálcio/farmacologia , Calmodulina/química , Calmodulina/genética , Calmodulina/farmacocinética , Relação Dose-Resposta a Droga , Polarização de Fluorescência , Humanos , Complexos Multiproteicos/metabolismo , Mutagênese , Fosfatidilinositol 4,5-Difosfato/genética , Fosfatidilinositol 4,5-Difosfato/farmacocinética , Mutação Puntual/genética , Ligação Proteica/efeitos dos fármacos , Ligação Proteica/genética , Estrutura Terciária de Proteína , Ratos , Proteínas S100/química , Proteínas S100/genética , Proteínas S100/farmacocinética , Ressonância de Plasmônio de Superfície , Canais de Cátion TRPV/química , Tiorredoxinas/farmacologia
3.
J Membr Biol ; 220(1-3): 53-67, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18008024

RESUMO

We used two approaches to characterize the lateral mobility of phosphatidylinositol 4,5-bisphosphate (PIP(2)) in the plasmalemma of baby hamster kidney and Chinese hamster ovary fibroblasts. First, nitrobenzoxadiazole-labeled C6-phosphatidylcholine and C16-PIP(2) were incorporated into plasma membrane "lawns" ( approximately 20 x 30 microm) from these cells and into the outer monolayer of intact cells. Diffusion coefficients determined by fluorescence recovery after photobleaching were similar for the two lipids and were higher in lawns, approximately 0.3 microm(2)/s, than on the cell surface, approximately 0.1 microm(2)/s. For membrane lawns, the fractional recoveries (75-90%) were close to those expected from the fraction of total membrane bleached, and labeling by the probes was several times greater than for intact cells. Second, we analyzed cells expressing M1 muscarinic receptors and green fluorescent protein fused with PIP(2)-binding pleckstrin-homology domains, Tubby domains or diacylglycerol (DAG)-binding C1 domains. On-cell gigaseal patches were formed with pipette tips >5 microm in diameter. When the agonist carbachol (0.3 mM: ) was applied either within or outside of the pipette, lipid signals crossed the pipette barrier rapidly in both directions and membrane blebbing occurred on both membrane sides. Accurate simulations of lipid gradients required diffusion coefficients >1 microm(2)/s. Exogenous DAG also crossed the pipette barrier rapidly. In summary, we found no evidence for restricted diffusion of signaling lipids in these cells. The lower mobility and incorporation of phospholipid at the extracellular leaflet may reflect a more ordered and condensed extracellular monolayer, as expected from previous studies.


Assuntos
Membrana Celular/metabolismo , Fosfatidilinositol 4,5-Difosfato/metabolismo , Fosfatidilinositol 4,5-Difosfato/farmacocinética , Animais , Transporte Biológico , Células CHO , Linhagem Celular , Cricetinae , Cricetulus , Difusão , Diglicerídeos/metabolismo , Recuperação de Fluorescência Após Fotodegradação , Microdomínios da Membrana/metabolismo , Microscopia Confocal , Técnicas de Patch-Clamp
4.
J Neurosci Res ; 66(4): 540-50, 2001 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-11746373

RESUMO

Agonist- and guanine-nucleotide-stimulated phospholipase C-beta (PLC) activity was characterized in crude plasma membrane preparations from cerebral cortex, hippocampus and cerebellum of Ts65Dn mice, a model for Down syndrome, and their control littermates. The levels of expression of PLC-beta((1-4)) isoforms and G-protein alpha(q/11) subunits were also quantified by Western blot analysis to establish their contribution to the patterns of PLC functioning. PLC activity regulated by G-proteins and muscarinic and 5-HT(2) receptors presented a regional distribution in both control and Ts65Dn mice. In both groups of mice, the intensity of PLC responses to maximal activation by calcium followed the sequence cerebellum > cortex > hippocampus. Both basal and maximal PLC activities, however, were significantly lower in cerebellar membranes of Ts65Dn than in control mice. This difference was mostly revealed in crude plasma membranes prepared from cerebellum at the level of G-protein-dependent-PLC activity because the concentration-response curve to GTPgammaS showed a reduction of the maximal effect in Ts65Dn mice, with no change in sensitivity (EC(50)). Western blot analysis showed a heterogeneous distribution of PLC-beta((1-4)) isoforms in both groups of mice. The levels of PLC-beta4 isoform, however, were significantly lower in the cerebellum of Ts65Dn than in control mice. We conclude that the cerebellum of Ts65Dn mice has severe deficiencies in PLC activity stimulated by guanine nucleotides, which are specifically related to a lower level of expression of the PLC-beta4 isoform, a fact that may account for the neurological phenotype observed in this murine model of Down syndrome.


Assuntos
Membrana Celular/enzimologia , Cerebelo/enzimologia , Síndrome de Down/enzimologia , Regulação para Baixo/genética , Proteínas de Ligação ao GTP/genética , Regulação Enzimológica da Expressão Gênica/genética , Isoenzimas/deficiência , Fosfolipases Tipo C/deficiência , Animais , Cálcio/metabolismo , Cálcio/farmacologia , Membrana Celular/efeitos dos fármacos , Membrana Celular/genética , Cerebelo/efeitos dos fármacos , Cerebelo/fisiopatologia , Córtex Cerebral/enzimologia , Córtex Cerebral/fisiopatologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Síndrome de Down/genética , Síndrome de Down/fisiopatologia , Regulação para Baixo/efeitos dos fármacos , Proteínas de Ligação ao GTP/efeitos dos fármacos , Proteínas de Ligação ao GTP/metabolismo , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Guanosina 5'-O-(3-Tiotrifosfato)/farmacocinética , Isoenzimas/genética , Masculino , Camundongos , Camundongos Mutantes Neurológicos , Agonistas Muscarínicos/farmacologia , Antagonistas Muscarínicos/farmacologia , Fosfatidilinositol 4,5-Difosfato/genética , Fosfatidilinositol 4,5-Difosfato/metabolismo , Fosfatidilinositol 4,5-Difosfato/farmacocinética , Fosfolipase C beta , Isoformas de Proteínas/deficiência , Isoformas de Proteínas/genética , Receptor 5-HT2A de Serotonina , Receptores Muscarínicos/efeitos dos fármacos , Receptores Muscarínicos/metabolismo , Receptores de Serotonina/efeitos dos fármacos , Receptores de Serotonina/metabolismo , Antagonistas da Serotonina/farmacologia , Agonistas do Receptor de Serotonina/farmacologia , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Frações Subcelulares/efeitos dos fármacos , Frações Subcelulares/enzimologia , Trítio/farmacocinética , Fosfolipases Tipo C/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA